Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence
Although mangiferin (MGN) is a natural antioxidant that could be a good candidate for the treatment of ocular diseases, its use in ophthalmology is strongly compromised due to its high lipophilicity. Its encapsulation in nanostructured lipid carriers (NLC) seems to be an interesting strategy for imp...
Main Authors: | Debora Santonocito, Ignazio Barbagallo, Alfio Distefano, Giuseppe Sferrazzo, Maria Vivero-Lopez, Maria Grazia Sarpietro, Carmelo Puglia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/951 |
Similar Items
-
Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study
by: Debora Santonocito, et al.
Published: (2022-02-01) -
Ethosomes and Transethosomes for Mangiferin Transdermal Delivery
by: Maddalena Sguizzato, et al.
Published: (2021-05-01) -
Mangiferin for the Management of Liver Diseases: A Review
by: Lisi Li, et al.
Published: (2023-06-01) -
Solubility, Antioxidation, and Oral Bioavailability Improvement of Mangiferin Microparticles Prepared Using the Supercritical Antisolvent Method
by: Mengran Liu, et al.
Published: (2020-01-01) -
Inhibition of Peroxidation Potential and Protein Oxidative Damage by Metal Mangiferin Complexes
by: Alberto J. Nuñez-Selles, et al.
Published: (2022-02-01)